Page last updated: 2024-10-29

imipramine and Vascular Diseases

imipramine has been researched along with Vascular Diseases in 2 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, X1
Emery, CJ1
Laude, E1
Herget, J1
Gill, G1
Cope, G1
Barer, GR1
Haefely, W1

Reviews

1 review available for imipramine and Vascular Diseases

ArticleYear
[Drugs with effect on the adrenergic nerve fiber].
    Pharmaceutica acta Helvetiae, 1968, Volume: 43, Issue:12

    Topics: Aminocaproates; Amitriptyline; Amphetamine; Bretylium Compounds; Chlorpromazine; Disulfiram; Dopamin

1968

Other Studies

1 other study available for imipramine and Vascular Diseases

ArticleYear
Adverse pulmonary vascular effects of high dose tricyclic antidepressants: acute and chronic animal studies.
    The European respiratory journal, 2002, Volume: 20, Issue:2

    Topics: Acute Disease; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Cats; Chronic Disease; Dise

2002